Catalyst
Slingshot members are tracking this event:
TG Therapeutics (TGTX) Announces Orphan Drug Designation for the Combination of TG-1101 and TGR-1202 for Treatment of Chronic Lymphocytic Leukemia
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TGTX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 09, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Tgr-1202, Tg-1101, Orphan Drug Designation, Chronic Lymphocytic Leukemia
